TCL Archive Conversation with The Cancer Letter: Pat White: NIH Funding “Our Only Concern” By Cancer History Project September 26, 2014
TCL Archive Afinitor Increases Overall Survival To 3.5 Years in Phase III Trial By Cancer History Project September 26, 2014
TCL Archive Gonzalez-Angulo Found Guilty in MD Anderson Poisoning Case By Cancer History Project September 26, 2014
TCL Archive Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials By Cancer History Project September 26, 2014
TCL Archive Guest Editorial “Gizmo Idolatry” and Marketing Da Vinci’s Radical Robot By Cancer History Project September 26, 2014
TCL Archive Phase III Trial: Panobinostat Increases PFS by Four Months By Cancer History Project September 26, 2014
TCL Archive MD Anderson Expands Reach Into Florida, Ohio By Cancer History Project September 26, 2014
TCL Archive Phase III Cyramza Trial Meets OS Primary Endpoint By Cancer History Project September 26, 2014
Article Elaine Nord, photographer and neuroendocrine cancer survivor, speaks at the 2024 NETRF Symposium By NETRF
Article Ramesh Shivdasani: Viewing Intestinal NETs Through the Lens of Normal Human Enteroendocrine Cell Differentiation By NETRF
